KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Operating Expenses (2019 - 2025)

Historic Operating Expenses for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $181.4 million.

  • GoodRx Holdings' Operating Expenses rose 375.42% to $181.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $717.7 million, marking a year-over-year decrease of 569.57%. This contributed to the annual value of $726.5 million for FY2024, which is 653.49% down from last year.
  • Per GoodRx Holdings' latest filing, its Operating Expenses stood at $181.4 million for Q3 2025, which was up 375.42% from $176.3 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Operating Expenses high stood at $218.3 million for Q3 2023, and its period low was $165.4 million during Q1 2021.
  • For the 5-year period, GoodRx Holdings' Operating Expenses averaged around $186.2 million, with its median value being $181.4 million (2025).
  • Over the last 5 years, GoodRx Holdings' Operating Expenses had its largest YoY gain of 11700.36% in 2021, and its largest YoY loss of 5551.72% in 2021.
  • GoodRx Holdings' Operating Expenses (Quarter) stood at $201.5 million in 2021, then dropped by 9.49% to $182.4 million in 2022, then increased by 17.85% to $214.9 million in 2023, then decreased by 16.07% to $180.4 million in 2024, then rose by 0.56% to $181.4 million in 2025.
  • Its Operating Expenses was $181.4 million in Q3 2025, compared to $176.3 million in Q2 2025 and $179.6 million in Q1 2025.